<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Oxidative modification of carbohydrates and <z:chebi fb="23" ids="18059">lipids</z:chebi> enhances the formation of advanced glycation end products (AGEs), which are formed not only in <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>, but also in normoglycemia </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we determined skin AGEs in patients with <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>PATIENTS AND METHODS: We non-invasively measured skin autofluorescence (AF) levels in patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> (CCI; n=95), patients with silent <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> (SBI; n=40), and age-matched controls (n=34), using an AGE Reader </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Skin AF levels in patients with CCI and SBI were significantly increased compared with those in the control group (2.06+/-0.38, 2.16+/-0.47 and 1.84+/-0.35, respectively) </plain></SENT>
<SENT sid="4" pm="."><plain>Angiotension receptor blocker (ARB) or <z:chebi fb="0" ids="35664">statins</z:chebi> had no significant effect on the level of advanced glycation in any of the groups </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSION: Our data suggest that increased formation of AGEs may be an indicator of <z:mp ids='MP_0003674'>oxidative stress</z:mp>, not only in <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:hpo ids='HP_0000083'>renal failure</z:hpo>, but also in <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
</text></document>